Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Business of Medicine

In the last quarter of 2014, EpiFix, a dehydrated human amnion/chorion membrane (dHACM) allograft, underwent a randomized / controlled trial comparison against a leading living-cell based skin substitute, Apligraf. The EpiFix product was shown to heal...
Recent trials from Celldex Therapeutics Inc have demonstrated the potential of their new vaccine, Rintega, in treating patients with glioblastoma multiforme (GBM) by utilizing the immune system in conjunction with other drugs, reports Reuters. Of the 73...
Each week, The Doctor's Channel and IMS Health's Appscript.net present you with a useful and thoughtfully designed app that can help both patients and their physicians with health-related matters.